Moneycontrol Bureau Here are three strategies on three stocks by brokerage firms.Biocon Citi maintains buy call on it as Biocon makes regulatory filing of Gargine in Europe. It says the Biocon is most leveraged play on global biosimilars opportunity.
M&MNomura upgrades it to buy from neutral but cuts target to Rs 1586 from Rs 1592 per share as market share pressure in compact UV may continue. It has raised tractor volume growth estimate to 25 percent from 22 percent for FY17. It has lowered FY17-19 volume estimates for UV segment by 5-6 percent.
CESC CLSA maintains buy after the recent correction but cuts FY17-19 EPS estimates by 3 percent and slashed target to Rs 745 from Rs 775 per share.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
